|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
1998-4-10
|
|
pubmed:abstractText |
The efficacy of antiresorptive therapy in preventing fractures in women at highest fracture risk, such as very elderly women or those with severe osteoporosis, is uncertain.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
157
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2617-24
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9531231-Administration, Oral,
pubmed-meshheading:9531231-Age Factors,
pubmed-meshheading:9531231-Aged,
pubmed-meshheading:9531231-Aged, 80 and over,
pubmed-meshheading:9531231-Alendronate,
pubmed-meshheading:9531231-Double-Blind Method,
pubmed-meshheading:9531231-Drug Administration Schedule,
pubmed-meshheading:9531231-Female,
pubmed-meshheading:9531231-Femoral Neck Fractures,
pubmed-meshheading:9531231-Fractures, Bone,
pubmed-meshheading:9531231-Humans,
pubmed-meshheading:9531231-Middle Aged,
pubmed-meshheading:9531231-Osteoporosis, Postmenopausal,
pubmed-meshheading:9531231-Spinal Fractures,
pubmed-meshheading:9531231-Treatment Outcome
|
|
pubmed:articleTitle |
Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
|
|
pubmed:affiliation |
Department of Medicine, Veterans Affairs Medical Center, and School of Public Health, University of Minnesota, Minneapolis 55417, USA. ensru001@maroon.tc.umn.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
